Restenil en es it fr

Restenil Brand names, Restenil Analogs

Restenil Brand Names Mixture

  • No information avaliable

Restenil Chemical_Formula


Restenil RX_link

No information avaliable

Restenil fda sheet

Restenil msds (material safety sheet)

Restenil Synthesis Reference

No information avaliable

Restenil Molecular Weight

309.469 g/mol

Restenil Melting Point

< 25 oC

Restenil H2O Solubility

Soluble as HCl salt

Restenil State


Restenil LogP


Restenil Dosage Forms

Tablets (oral, 1 mg)

Restenil Indication

Used for the symptomatic treatment of parkinsonism.

Restenil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Restenil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Restenil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Restenil Patient Information

Restenil Organisms Affected

Humans and other mammals